$IMUX Cashflow Statement | Understand Stock

$IMUX

$8.15 +$0.54 (7.03%) Live

$IMUX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Goodwill impairment (see Note 2)
Non-cash lease expense
Stock-based compensation
Change in fair value of tranche rights
Fees expensed as part of January 2024 Financing
Foreign currency loss
Common stock issued in connection with the 4SC royalty settlement (see Note 4)
Changes in operating assets and liabilities:
Other current assets and prepaid expenses
Accounts payable
Operating lease liabilities
Other liabilities
Accrued expenses

Net cash used in operating activities
Cash flows from investing activities:
Purchases of Investments-other
Sales of Investments-other
Purchases of property and equipment
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from January 2024 Financing, net of issuance costs
January2024 P I P E Transaction
May 2025 P I P E Transaction
April 2025 P I P E Transaction
Total proceeds from January 2024 Financing, net of issuance costs
Proceeds from shares issued in connection with the Company's employee stock purchase plan
Proceeds from the exercise of stock options
Proceeds from the exercise of pre-funded warrants
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents
Net change in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Common stock issued in connection with the 4SC royalty settlement (see Note 4)
Supplemental disclosure of noncash investing and financing activities:
Conversion of tranche rights liability to equity upon increase in authorized shares
Operating lease right-of use asset obtained in exchange for lease obligation
Offering costs in accrued expenses

Comments